Octreotide acetate Prescribing at MYRTLE GROUP PRACTICE
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
10
Total Quantity
100
NHS Cost
£2.7K
vs National Avg
+60.9%
MYRTLE GROUP PRACTICE prescribed 10 items of Octreotide acetate over the last 12 months at a cost of £2,732 to the NHS. This is 60.9% above the national average prescribing rate. Octreotide acetate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
No monthly data available.
Prescribing Details
| Total Items | 10 |
|---|---|
| Total Quantity | 100 |
| Total NHS Cost | £2,732 |
| Presentations | 3 different forms |
| vs National Average | +60.9% |
Octreotide acetate Prescribing Comparison
| This practice | 10 items |
|---|---|
| National average per practice | 6 items |
| Difference | +60.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.